Literature DB >> 18440234

Design, synthesis, and biological evaluation of thiophene analogues of chalcones.

Romeo Romagnoli1, Pier Giovanni Baraldi, Maria Dora Carrion, Carlota Lopez Cara, Olga Cruz-Lopez, Delia Preti, Manlio Tolomeo, Stefania Grimaudo, Antonella Di Cristina, Nicola Zonta, Jan Balzarini, Andrea Brancale, Taradas Sarkar, Ernest Hamel.   

Abstract

Chalcones are characterized by possessing an enone moiety between two aromatic rings. A series of chalcone-like agents, in which the double bond of the enone system is embedded within a thiophene ring, were synthesized and evaluated for antiproliferative activity and inhibition of tubulin assembly and colchicine binding to tubulin. The replacement of the double bond with a thiophene maintains antiproliferative activity and therefore must not significantly alter the relative conformation of the two aryl rings. The synthesized compounds were found to inhibit the growth of several cancer cell lines at nanomolar to low micromolar concentrations. In general, all compounds having significant antiproliferative activity inhibited tubulin polymerization with an IC(50)<2microM. Several of these compounds caused K562 cells to arrest in the G2/M phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440234     DOI: 10.1016/j.bmc.2008.04.026

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  17 in total

1.  New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancer.

Authors:  Juan Rodrigues; Claudia Abramjuk; Luis Vásquez; Neira Gamboa; José Domínguez; Bianca Nitzsche; Michael Höpfner; Radostina Georgieva; Hans Bäumler; Carsten Stephan; Klaus Jung; Michael Lein; Anja Rabien
Journal:  Pharm Res       Date:  2010-12-24       Impact factor: 4.200

2.  One-pot synthesis of cinnamylideneacetophenones and their in vitro cytotoxicity in breast cancer cells.

Authors:  David J Weldon; Marilyn D Saulsbury; Joshua Goh; Leah Rowland; Petreena Campbell; Laijia Robinson; Calvin Miller; Joshua Christian; Louisa Amis; Nia Taylor; Cassandra Dill; Willie Davis; Stanley L Evans; Eileen Brantley
Journal:  Bioorg Med Chem Lett       Date:  2014-06-04       Impact factor: 2.823

Review 3.  Molecular targeted approaches to cancer therapy and prevention using chalcones.

Authors:  Danielle D Jandial; Christopher A Blair; Saiyang Zhang; Lauren S Krill; Yan-Bing Zhang; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

4.  One-pot diastreoselective synthesis of highly functionalized cyclohexenones: 2-oxo-N,4,6-triarylcyclohex-3-enecarboxamides.

Authors:  Mir Rasul Mousavi; Malek Taher Maghsoodlou; Sayyed Mostafa Habibi-Khorassani
Journal:  Mol Divers       Date:  2014-08-06       Impact factor: 2.943

5.  Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors.

Authors:  Lívia B Salum; Wanessa F Altei; Louise D Chiaradia; Marlon N S Cordeiro; Rafael R Canevarolo; Carolina P S Melo; Evelyn Winter; Bruno Mattei; Hikmat N Daghestani; Maria Cláudia Santos-Silva; Tânia B Creczynski-Pasa; Rosendo A Yunes; José A Yunes; Adriano D Andricopulo; Billy W Day; Ricardo J Nunes; Andreas Vogt
Journal:  Eur J Med Chem       Date:  2013-03-06       Impact factor: 6.514

6.  Straightforward synthesis of thiazoline-incorporated chalconoids from phenacyl halides.

Authors:  Adile Ayati; Saeed Emami
Journal:  Mol Divers       Date:  2013-01-12       Impact factor: 2.943

7.  (E)-1-(4-Amino-phen-yl)-3-(2,4,5-trimeth-oxy-phen-yl)prop-2-en-1-one.

Authors:  Hoong-Kun Fun; Thawanrat Kobkeatthawin; Pumsak Ruanwas; Suchada Chantrapromma
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-10

8.  3,5,4'-trihydroxy-6,7,3'-trimethoxyflavone protects against beta amyloid-induced neurotoxicity through antioxidative activity and interference with cell signaling.

Authors:  Alona Telerman; Rivka Ofir; Yoel Kashman; Anat Elmann
Journal:  BMC Complement Altern Med       Date:  2017-06-23       Impact factor: 3.659

9.  A novel chalcone derivative which acts as a microtubule depolymerising agent and an inhibitor of P-gp and BCRP in in-vitro and in-vivo glioblastoma models.

Authors:  Ahcene Boumendjel; Anne McLeer-Florin; Pierre Champelovier; Diane Allegro; Dima Muhammad; Florence Souard; Madiha Derouazi; Vincent Peyrot; Bertrand Toussaint; Jean Boutonnat
Journal:  BMC Cancer       Date:  2009-07-20       Impact factor: 4.430

10.  Protective and antioxidant effects of a chalconoid from Pulicaria incisa on brain astrocytes.

Authors:  Anat Elmann; Alona Telerman; Hilla Erlank; Sharon Mordechay; Miriam Rindner; Rivka Ofir; Yoel Kashman
Journal:  Oxid Med Cell Longev       Date:  2013-08-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.